Post Holdings Reports Results for the Second Quarter of Fiscal Year 2024; Raises Fiscal Year 2024 Outlook ST. LOUIS, May 02, 2024 (GLOBE NEWSWIRE) -- Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today reported results for the second fiscal quarter ended March 31, 2024. Highlights: Second quarter net sales of $2.0 billionOperating profit of $190.1 million; net earnings of $97.2 million and Adjusted EBITDA (non-GAAP)* of $345.2 millionRaised fiscal year 2024 Adjusted EBITDA (non-GAAP)* outlook to $1,335-$1,375 million *For additional information regarding n...
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting Company to host an event featuring key opinion leaders (KOLs) on Friday, May 31st in Chicago to highlight the ongoing clinical development of UNO HAMILTON, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors, today announced being selected to present on the clinica...
HOUSTON--(BUSINESS WIRE)-- DNOW Inc. (NYSE:DNOW) has scheduled a conference call to discuss the results for the first quarter of 2024 on Friday, May 10, 2024 at 8:00 am (US Central Time). Financial results for the first quarter ending on March 31, 2024 are expected to be released that morning before the market opens. The call will be broadcast through the Investor Relations link on DNOW’s web site at on a listen-only basis. Listeners should log in prior to the start of the call to register for the webcast. A replay of the call will be available online for thirty days following the conferenc...
Post Holdings Schedules Second Quarter Fiscal Year 2024 Conference Call ST. LOUIS, April 11, 2024 (GLOBE NEWSWIRE) -- Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today announced it will hold a conference call on Friday, May 3, 2024 at 9:00 a.m. ET to discuss financial results for the second quarter of fiscal year 2024 and fiscal year 2024 outlook and to respond to questions. Robert V. Vitale, President and Chief Executive Officer, Jeff A. Zadoks, Executive Vice President and Chief Operating Officer, and Matthew J. Mainer, Senior Vice President, Chief Financ...
Long-Term Breakouts for Emerging & Frontier Markets The bullish outlook we initiated in early November 2023 remains intact. The S&P 500 and Nasdaq 100 (QQQ) still refuse to close below their 20-day MAs/21-day EMAs for more than 2-3 consecutive days -- and even if/when they do, important supports are close by, including at 4983-5050 on the S&P 500 and $425-$433 on QQQ (gap supports from 2/22/24). The Fed's next move is almost guaranteed to be a cut (though when it happens is up for debate). And ...
Four Directors at Herbalife Ltd bought 26,077 shares at between 9.300USD and 9.420USD. The significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants GARDEN CITY, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders and solid tumors (through its affiliate Beyond Cancer, Ltd. (“Beyond Cancer”)), today announced that it has entered into a securities pur...
HOUSTON--(BUSINESS WIRE)-- DNOW Inc. (NYSE: DNOW) announced today it has completed its all-cash acquisition of Whitco Supply, LLC, after the conclusion of the regulatory approval process and other customary closing conditions. The acquisition of Whitco Supply enhances DNOW's capabilities and position in the midstream, E&P and targeted adjacent markets that have been core to the company’s growth strategy, while increasing the company’s earnings and free cash flow capacity. The deployment of capital strategically aligns with and reinforces the company’s commitment to increase long-term value f...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.